TFAP2A and branchiooculofacial syndrome: The TFAP2A gene was first linked to the clinical presentation of BOFS in 2008.[1] Among BOFS cases, 95% had TFAP2A gene coding sequence alterations in genetic testing, mainly involving exon 4 (82%), exon 5 (14%), and the remaining exons accounting for 4%.